Trials / Completed
CompletedNCT05522998
Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy
Efficacy and Safety of Ciprofol for the Induction of General Anesthesia in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 212 (actual)
- Sponsor
- The Third People's Hospital of Chengdu · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of ciprofol for the induction of general anesthesia in obese patients undergoing laparoscopic sleeve gastrectomy. A randomized, parallel, propofol injection positive control study will be conducted to select obese patients who will undergo laparoscopic sleeve gastrectomy in the author's hospital. To evaluate the efficacy and safety, the main observation index, secondary observation indexes, safety evaluation indexes, and the incidence of postoperative adverse reactions will be recorded and compared between the two groups.
Detailed description
To evaluate the efficacy and safety of ciprofol for the induction of general anesthesia in obese patients undergoing laparoscopic sleeve gastrectomy. A randomized, parallel, propofol injection positive control study will be conducted to select obese patients who will undergo laparoscopic sleeve gastrectomy in the author's hospital. To evaluate the efficacy and safety, the following indexes will be recorded and compared between the two groups. * The main observation index:(1) The rate of successful anesthesia induction * Secondary observation indexex:(1) Time from initial administration of study drug to loss of consciousness; (2) Time from initial administration of study drug to disappearance of eyelash reflex; (3) Changes in bispectral index(BIS) values during anesthesia induction * Safety evaluation indexes:(1) Adverse events; (2) Intubation response rate; (3) Vital signs; (4) Evaluation of injection pain * Adverse events to be focused on:(1)The incidence of blood pressure reduction requiring treatment during anesthesia induction; (2) The incidence of respiratory depression
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ciprofol | Ciprofol (0.4-0.5mg/kg) for anesthesia induction |
| DRUG | Propofol | propofol(2-2.5mg/kg) for anesthesia induction |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-06-30
- Completion
- 2024-07-30
- First posted
- 2022-08-31
- Last updated
- 2024-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05522998. Inclusion in this directory is not an endorsement.